SCHEMBL19636411

SCHEMBL19636411

CCC(C)(C)CC(C)(C)NC(=N)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18520505 0.83
SCHEMBL21743333 0.81
SCHEMBL25015251 0.81
SCHEMBL18520678 0.81
SCHEMBL12458682 0.81 ALDH1A1 (0.31)
Guanoctine SCHEMBL5909699 0.79 POLB (0.38)
SCHEMBL11416809 0.78 EPHX1 (0.32)
Guanoctine SCHEMBL121121 0.77 POLB (0.37)
SCHEMBL27115012 0.77
SCHEMBL20669482 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021202694-A1 PHENOLIC ACID LIPID BASED CATIONIC LIPIDS TRANSLATE BIO, INC. (US) 2021-10-07 WO disclosed
WO-2017201433-A1 COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF MITOCHONDRIAL MYOPATHIES STEALTH BIOTHERAPEUTICS CORP (MC) 2017-11-23 WO disclosed